| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.3M | +615.4% |
| R&D Expense | $6.1M | -12.9% |
| SG&A Expense | $12.6M | +22.9% |
| Operating Income | -$12.6M | +34.9% |
| Interest Expense | $1.6M | -0.3% |
| Net Income | $10.5M | +122.5% |
| EPS (Basic) | $0.09 | +114.5% |
| EPS (Diluted) | $0.09 | +114.5% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.8M | +50.1% |
| Short-term Investments | $18.9M | — |
| Accounts Receivable | $0 | -100.0% |
| Current Assets | $23.2M | -24.7% |
| Total Assets | $106.5M | +6.4% |
| Current Liabilities | $14.8M | -53.1% |
| Long-term Debt | $9.9M | +24.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$13.6M | -12.6% |
| Investing Cash Flow | $3.6M | +197.3% |
| Financing Cash Flow | $11.3M | -9.5% |
| Total Liabilities |
| $28.2M |
| -35.5% |
| Stockholders' Equity | $78.3M | +46.0% |